SCHEMBL648808

SCHEMBL648808

C/C(=C/C(=O)O)CCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8372870 1.00
SCHEMBL1645858 1.00
SCHEMBL17670624 0.85 KDM4E (0.54)
SCHEMBL17670623 0.85 KDM4E (0.54)
SCHEMBL17775763 0.81
SCHEMBL195384 0.79
SCHEMBL11849467 0.79 KDM4E (0.58)
SCHEMBL2152750 0.79
SCHEMBL11849463 0.79 KDM4E (0.58)
SCHEMBL196084 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0487731-A1 OPTICALLY ACTIVE EPOXYCYCLOHEXANE DERIVATIVE, OPTICALLY ACTIVE EPOXYCYCLOHEXANONE DERIVATIVE, AND PRODUCTION OF SAID DERIVATIVES SAGAMI CHEMICAL RESEARCH CENTER (JP) 1992-06-03 EP claimed
JP-3184966-A None JP disclosed
EP-4296365-A2 PROCESSES FOR CONVERSION OF BIOLOGICALLY DERIVED MEVALONIC ACID Visolis, Inc. (US) 2023-12-27 EP disclosed
CN-112279744-B Method for the conversion of biologically derived mevalonate 维索利斯有限公司 2023-08-15 CN disclosed
US-11111206-B2 Monomers and polymers formed thereby REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2021-09-07 US disclosed
CN-107002104-B Method for conversion of biologically derived mevalonate 维索利斯有限公司 2021-08-17 CN disclosed
US-20210078966-A1 PROCESSES FOR CONVERSION OF BIOLOGICALLY DERIVED MEVALONIC ACID Visolis, Inc. 2021-03-18 US disclosed
US-20210078966-A1 PROCESSES FOR CONVERSION OF BIOLOGICALLY DERIVED MEVALONIC ACID Visolis, Inc. 2021-03-18 US disclosed
CN-112279744-A Method for conversion of biologically derived mevalonate 维索利斯有限公司 2021-01-29 CN disclosed
US-10807963-B2 Processes for conversion of biologically derived mevalonic acid Visolis, Inc. (US) 2020-10-20 US disclosed
WO-2011048034-A1 NOVEL RUBBER MIXTURES LANXESS DEUTSCHLAND GMBH (DE) 2011-04-28 WO disclosed
EP-2311907-A1 New rubber mixtures LANXESS Deutschland GmbH (DE) 2011-04-20 EP disclosed
EP-2186651-A1 Hydroxyl modified microgel lattices which can be stored safely for a long time Lanxess Deutschland GmbH (DE) 2010-05-19 EP disclosed
US-20100120973-A1 STORAGE-STABLE, HYDROXY-MODIFIED MICROGEL LATICES LANXESS DEUTSCHLAND GMBH (DE) 2010-05-13 US disclosed
US-5254694-A Optically active epoxycyclohexane derivative and epoxycyclohexanone derivative, and process for the preparation thereof SAGAMI CHEMICAL RESEARCH CENTER (JP) 1993-10-19 US disclosed
US-5254694-A Optically active epoxycyclohexane derivative and epoxycyclohexanone derivative, and process for the preparation thereof SAGAMI CHEMICAL RESEARCH CENTER (JP) 1993-10-19 US disclosed
EP-0487731-A1 OPTICALLY ACTIVE EPOXYCYCLOHEXANE DERIVATIVE, OPTICALLY ACTIVE EPOXYCYCLOHEXANONE DERIVATIVE, AND PRODUCTION OF SAID DERIVATIVES SAGAMI CHEMICAL RESEARCH CENTER (JP) 1992-06-03 EP disclosed
EP-0487731-A1 OPTICALLY ACTIVE EPOXYCYCLOHEXANE DERIVATIVE, OPTICALLY ACTIVE EPOXYCYCLOHEXANONE DERIVATIVE, AND PRODUCTION OF SAID DERIVATIVES SAGAMI CHEMICAL RESEARCH CENTER (JP) 1992-06-03 EP disclosed
JP-H03184966-A OPTICALLY ACTIVE EPOXYCYCLOHEXANE DERIVATIVE, OPTICALLY ACTIVE EPOXYCYCLOHEXANONE DERIVATIVE AND PRODUCTION THEREOF SAGAMI CHEM RES CENTER 1991-08-12 JP disclosed
WO-1991002728-A1 OPTICALLY ACTIVE EPOXYCYCLOHEXANE DERIVATIVE, OPTICALLY ACTIVE EPOXYCYCLOHEXANONE DERIVATIVE, AND PRODUCTION OF SAID DERIVATIVES SAGAMI CHEMICAL RESEARCH CENTER (JP) 1991-03-07 WO disclosed